drugset / Trial / NCT02344069

Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage

NCT02344069

Phase 2 Completed 40 enrolled Rigshospitalet, Denmark CSL Behring · collab
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Effect of immediate, pre-emptive fibrinogen concentrate in patients with trauma haemorrhage needing haemostatic resuscitation - a randomized, controlled, double-blinded investigator-initiated pilot trial

Timeline

Start
2015-02
Primary completion
2017-03
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fibrinogen Concentrate Human Protein / enzyme biologic 60 mg/kg Intravenous
Comparator Fibrinogen Concentrate Human Protein / enzyme biologic 70 mg/kg Intravenous

Indications